Announced Thu, 21 Aug · 18:22 IST

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 the 40th AGM of the Company was held on 21st August, 2025 through VC/OAVM and the business mentioned in the Notice dated 17th ....

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Gujarat Terce Laboratories held its 40th Annual General Meeting on 21st August 2025 via video conferencing, chaired by Managing Director & CEO Mr. Aalap Prajapati. Out of 13,904 shareholders on record, 31 attended (2 promoters and 29 public shareholders). A total of 8 resolutions were passed through remote e-voting, including 6 ordinary resolutions covering adoption of audited financial statements for FY ending March 2025, re-appointment of a director retiring by rotation, re-appointment of statutory and secretarial auditors, regularization of an independent director, and ratification of cost auditor remuneration. Two special resolutions were also approved — one to sell the factory located at Ravi Estate, Bileshwarpura, Chhatral, Gandhinagar, and another to approve enhanced limits for loans and investments under Section 186 of the Companies Act, 2013. All resolutions were passed with the requisite majority.

Likely market impact

Shareholders should note the special resolution to sell the company's factory at Chhatral, Gandhinagar, which signals a potential restructuring or scaling-down of manufacturing operations, while the Section 186 approval gives the company wider latitude to lend or invest funds. Both items could materially affect the company's future business profile and should be monitored.